These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients. He YM; Yang XJ; Zhao X; Cheng XJ; Xu HF; Qian YX; Li X Clin Cardiol; 2012 Aug; 35(8):505-11. PubMed ID: 22488122 [TBL] [Abstract][Full Text] [Related]
23. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis. Lee S; Spencer A J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736 [TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925 [TBL] [Abstract][Full Text] [Related]
25. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357 [TBL] [Abstract][Full Text] [Related]
26. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure? Doggrell SA Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448 [TBL] [Abstract][Full Text] [Related]
27. Carvedilol versus other beta-blockers in heart failure. Doggrell SA Expert Opin Investig Drugs; 2001 May; 10(5):971-80. PubMed ID: 11322870 [TBL] [Abstract][Full Text] [Related]
28. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF. Wikstrand J; Wedel H; Castagno D; McMurray JJ J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421 [TBL] [Abstract][Full Text] [Related]
29. [Beta-adrenolytics in heart failure--are they all really equal?]. Filipiak KJ; Opolski G Przegl Lek; 2005; 62 Suppl 2():39-42. PubMed ID: 16623117 [TBL] [Abstract][Full Text] [Related]
30. Beta-blockers for chronic heart failure: surviving longer but feeling better? Bolger AP; Al-Nasser F Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210 [TBL] [Abstract][Full Text] [Related]
31. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB; Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643 [TBL] [Abstract][Full Text] [Related]
32. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Roughead EE; Barratt JD; Ramsay E; Pratt N; Ryan P; Peck R; Killer G; Gilbert AL Circ Heart Fail; 2009 Sep; 2(5):424-8. PubMed ID: 19808372 [TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure. Briasoulis A; Palla M; Afonso L Am J Cardiol; 2015 Apr; 115(8):1111-5. PubMed ID: 25708861 [TBL] [Abstract][Full Text] [Related]
34. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lubsen J; Lutiger B; Metra M; Remme WJ; Torp-Pedersen C; Scherhag A; Skene A; Lancet; 2003 Jul; 362(9377):7-13. PubMed ID: 12853193 [TBL] [Abstract][Full Text] [Related]
35. Beta-blocker benefit according to severity of heart failure. Bouzamondo A; Hulot JS; Sanchez P; Lechat P Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure. Talbert RL Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861 [TBL] [Abstract][Full Text] [Related]
37. Effects of beta-blockers on ventilation efficiency in heart failure. Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721 [TBL] [Abstract][Full Text] [Related]
38. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173 [TBL] [Abstract][Full Text] [Related]
39. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334 [TBL] [Abstract][Full Text] [Related]
40. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study. Fröhlich H; Zhao J; Täger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L Circ Heart Fail; 2015 Sep; 8(5):887-96. PubMed ID: 26175538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]